A simple comparison helps clarify trade-offs
Pharmacokinetics: blood-brain barrier and plasma stability A small set of pharmacokinetic studies in the early 1980s addressed two questions relevant to interpreting peripherally administered DSIP: does it cross the blood-brain barrier, and what is its plasma stability
Emerging evidence implicates programmed necrosis (necroptosis), pyroptosis (gasdermin-D pore formation) and ferroptosis (lipid peroxidation driven by iron accumulation) as additional contributors, implying multiple, drug-specific death executors [72, 79, 84,85,86]
Getting the correct dosage is critical because too little may not provide the benefits you desire, and too much can lead to discomfort or side effects
and (4) ceramides are deacylated by the ceramidases (CDase) to produce sphingosine